PRTA
Prothena·NASDAQ
--
--(--)
--
--(--)
6.73 / 10
Outperform
Sentiment is Outperform (6.73) and fund‑flow score 7.91 (good), with overall positive inflows except large‑cap negative trend. Analyst consensus is neutral (1 rating). Capital flow is supportive but analyst outlook remains cautious.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Brian AbrahamsNeutral
Date2026-02-20
InstitutionRBC Capital
Times predicted3
Historical Win Rate66.7%
What is the analyst consensus for PRTA?
- PRTA holds a Bullish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.73/10 (Outperform).
